CytoSorbents Stock Price - CTSO

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
After Hours
Last Trade
Last: $ 5.60 ▲ 0.07 (1.27%)
Company Name Stock Ticker Symbol Market Type
CytoSorbents Corporation CTSO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.03 0.55% 5.53 5.65 5.49 5.50 5.50 19:59:46
Bid Price Ask Price Spread Spread % News
2.85 6.90 4.05 58.7% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
831 146,300 $ 5.52 $ 807,001 244,590 3.68 - 13.95
Last Trade Time Type Quantity Stock Price Currency
17:04:02 formt 1,500 $ 5.60 USD

CytoSorbents Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 178.64M 32.30M $ -17.21M -0.56 -11.01 12.73M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 19.00 65.20%

more financials information »

CytoSorbents News

Loading Messages....

Latest CTSO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTSO Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week5.415.695.265.4775104k0.122.22%
1 Month4.895.694.294.8608135k0.6413.09%
3 Months6.657.853.685.5106176k-1.12-16.84%
6 Months7.888.343.686.1637144k-2.35-29.82%
1 Year12.9513.953.687.8674163k-7.42-57.30%
3 Years6.3814.953.37.9321164k-0.85-13.32%
5 Years0.22715.240.26.3054178k5.3032,336.12%

CytoSorbents Description

CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries.The Company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend, K ontrol, and DrugSorb. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending.


Your Recent History
NASDAQ
CTSO
CytoSorben..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.